CardioCare is presented as a new intelligence-based approach that aims to assist clinicians in identifying and treating patients with chronic heart disease. It is already used in more than 50 clinics and hospitals across the country.
It’s not uncommon for structural heart disease to go undiagnosed or undertreated. The secret to successfully treating structural heart disease is an accurate diagnosis of the disease and the problematic area within the heart. There is also a need for thorough follow-up.
CardioCare was established to assist physicians in the diagnosis and treatment of such patients. For example, the system may examine echocardiograms for signs of chronic heart disease. It can also provide detailed information about each patient to assist physicians in providing medical decisions.
Joel Portice, the CEO of the company, said that the goal of CardioCare is to accelerate change in today’s ineffective healthcare systems. CardioCare is committed to enhancing chronic heart patient treatment by providing valuable insights through comprehensive clinical knowledge, advanced AI-powered analysis, and innovative digital health systems.
Portice says that CardioCare’s AI-based approach has reached many achievements and commercial results over the last six years. It was created to close loopholes that prevent patients from receiving appropriate treatment while also raising the quality of care for structural heart disease patients.